Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01809067 · ClinicalTrials.gov registry record · NA

The Effects of Lavender Aromatherapy on Reducing Stress and Anxiety During MRI Procedures.

A NA study of Anxiety, sponsored by Allina Health System.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT01809067: Completed NA study of Anxiety, sponsored by Allina Health System.

NCT01809067 is a NA study of Anxiety that has completed, run by Allina Health System. The registered enrollment target is 60 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01809067, a NA study of Anxiety, has completed, sponsored by Allina Health System.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Research Question: What effect if any does the use of lavender aromatherapy have on a patient's stress and anxiety during the MRI procedure in the Cardiovascular Services Department? Hypothesis: 1. The use of lavender aromatherapy will reduce anxiety by 20% during MRI procedures. 2. MRI cancellations related to stress and anxiety will decrease by 10%. Sample size of 30 patients is needed for the control group and the lavender aromatherapy group, for a total of 60 patients. Rationale: Patients undergoing MRI procedures may experience stress and anxiety related to the small and confining space required during the scan. Anyone with a history of claustrophobia, panic attacks, or fear of enclosed spaces is more likely to experience symptoms of panic, fear, or anxiety during the MRI procedure (Harris, Cumming, \& Menzies, 2004, p. 1). This stress and anxiety may cause the patient to abort the scan, the patient may refuse future scans, or the patient's nervous tremors or involuntary quivering may adversely affect the images obtained. Lavender aromatherapy has been shown to reduce stress and anxiety for patients in other settings; however, its use during MRI procedures has not been studied. This project investigates the use of lavender aromatherapy as a non-pharmacological way to help patients relax during their MRI procedure. Lavender aromatherapy has been studied and shown to reduce stress and anxiety for patients in other situations, but it has not been studied during MRI procedures. Lavender is known to be uplifting, as well as soothing and helpful for reducing stress, anxiety, depression, and insomnia (Herz, 2007, p. 264). If aromatherapy proves useful as an agent to reduce stress and anxiety, patient satisfaction with their MRI procedure will increase and the need for sedating medication could decrease.

Primary Outcome

A comparison will be made between the two groups, one group using lavender aromatherapy and one group without aromatherapy. T-tests will be used to assess whether the two groups are statistically different from each other. Comparisons will be made by using information collected from the patient with this screening tool: (Patients will complete the screening tool before and after their MRI procedure.) State Trait Anxiety Scale (State portion only)

Conditions Studied

Interventions

  • OTHER Lavender aromatherapy inhalers

Study Locations (1)

Minnesota

  • Abbott Northwestern Hospital - Minneapolis

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2013-03
Est. Completion 2013-06
Phase NA
Allina Health System

32 total trials

What the finished NCT01809067 record still lists

NCT01809067 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Lavender aromatherapy inhalers is the first listed.

NCT01809067 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT01809067 about?

NCT01809067 is a clinical study titled "The Effects of Lavender Aromatherapy on Reducing Stress and Anxiety During MRI Procedures.". Research Question: What effect if any does the use of lavender aromatherapy have on a patient's stress and anxiety during the MRI procedure in the Cardiovascular Services Department? Hypothesis: 1. The use of lavender aromatherapy will reduce anxiety by 20% during MRI procedures. 2. MRI cancellat...

What is the current status of trial NCT01809067?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2013-03. Estimated completion is 2013-06.

What conditions does trial NCT01809067 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT01809067?

The interventions under investigation include: Lavender aromatherapy inhalers (OTHER).

Who is sponsoring clinical trial NCT01809067?

This trial is sponsored by Allina Health System, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01809067 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01809067's enrollment target sits among peer trials

60 230th of 364 higher than 127 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01809067, the US trial registry maintained by the National Library of Medicine. NCT01809067 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.